Survival and Health in Liveborn Infants with Transposition of Great Arteries—A Population-based Study
Article first published online: 6 JUN 2007
DOI: 10.1111/j.1747-0803.2007.00093.x
Additional Information
How to Cite
Garne, E., Loane, M. A., Nelen, V., Bakker, M. K., Gener, B., Abramsky, L., Addor, M.-C. and Queisser-Luft, A. (2007), Survival and Health in Liveborn Infants with Transposition of Great Arteries—A Population-based Study. Congenital Heart Disease, 2: 165–169. doi: 10.1111/j.1747-0803.2007.00093.x
Publication History
- Issue published online: 6 JUN 2007
- Article first published online: 6 JUN 2007
- Accepted in final form: March 20, 2007.
- Abstract
- Article
- References
- Cited By
Keywords:
- TGA;
- Prenatal Diagnosis;
- Survival;
- Normal Health
Abstract
Objective. To describe treatment, survival, and morbidity for liveborn infants with isolated transposition of great arteries (TGA).
Design. Population-based data from 7 European registries of congenital malformations (EUROCAT).
Results. Ninety-seven infants were diagnosed with isolated TGA and livebirth prevalence was 2.0 per 10 000 livebirths. The majority of infants were treated with prostaglandins (83%) and 57% had a catheter atrial septostomia performed. Arterial switch surgery was performed in 78 infants, other or unknown type of surgery was performed in 3 cases, and for 6 infants there was no information on surgery. At 1 year of age 69 infants were alive (71%) and 24 (25%) were dead (4 unknown). There were 10 deaths before surgery and 58% of all deaths took place during the first week. There was no statistically significant regional difference in mortality. Eight infants diagnosed prenatally all survived to 1 year and only 71% of infants diagnosed after birth survived (P = 0.08). Data on morbidity at 1 year of age was available for 57 infants. Fifty-one infants were reported with normal health and development.
Conclusions. In this population-based study survival for liveborn infants with TGA is lower than in studies published from tertiary centers. Outcome for survivors at 1 year of age seems favorable.

1747-0803/asset/CHD_left.gif?v=1&s=bd0b565b59c203813588264953c53dc395d76851)
1747-0803/asset/CHD_right.gif?v=1&s=991bf5f3d88147d48a4d0b7d464f8b48dd65f0b0)
